Publications & Presentations

making our mark

December 1, 2021
Scientific Meeting
SABCS 2021

Tumor-Released Circulating Orphan Noncoding RNAs Reflect Treatment Response and Survival in Breast Cancer

Liquid biopsies have emerged as effective diagnostic tools in disease monitoring and minimal residual disease detection. Circulating tumor DNA (ctDNA) was recently shown to be a predictor of poor response and recurrence in breast cancer. However, ctDNA shedding from breast tumors can rapidly decrease during treatment, resulting in reduced sensitivity in measuring early changes in tumor response or residual cancer burden (RCB) after neoadjuvant chemotherapy (NAC).

View the poster

The logo describing this publication.

want to learn more?
connect with us.

contact us
Close the cookie popup
Cookie Settings
By clicking "Accept All", you are agreeing to store cookies on your device to enhance your experience and help Exai's marketing.
Accept All
cookie settings